Evidence map›Paper›PMID 39452195›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive

Severin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, Adrian Egli, Stephan Moser, Vladimira Hinic, Richard Kuehl, Stefano Bassetti, Martin Siegemund, Katharina M Rentsch and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Severin BauschDivision of Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland.
Sarah DrägerDivision of Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland.
Panteleimon Charitos-FragkakisDivision of Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland.
Adrian EgliDivision of Clinical Bacteriology and Mycology, University Hospital Basel, 4031 Basel, Switzerland.
Stephan MoserDivision of Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0002-6184-494X
Vladimira HinicDivision of Clinical Bacteriology and Mycology, University Hospital Basel, 4031 Basel, Switzerland.
Richard KuehlDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, 4031 Basel, Switzerland.
Stefano BassettiDivision of Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0003-1729-1425
Martin SiegemundIntensive Care Unit, Department of Acute Medicine, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0002-2013-4140
Katharina M RentschDepartment of Laboratory Medicine, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0002-6585-9778
Laura HermannDivision of Clinical Pharmacology & Toxicology, Department of Internal Medicine, University Hospital Bern, 3010 Bern, Switzerland.
Verena SchöningDivision of Clinical Pharmacology & Toxicology, Department of Internal Medicine, University Hospital Bern, 3010 Bern, Switzerland.ORCID 0000-0003-2105-326X
Felix HammannDivision of Clinical Pharmacology & Toxicology, Department of Internal Medicine, University Hospital Bern, 3010 Bern, Switzerland.ORCID 0000-0003-0658-9330
Parham SendiDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, 4031 Basel, Switzerland.
Michael OsthoffDivision of Internal Medicine, University Hospital Basel, 4031 Basel, Switzerland.ORCID 0000-0001-5439-957X

Funding

Freiwillige Akademische Gesellschaft project grant
6 · The paper itself

Abstract

This study aimed to determine cefazolin target attainment in patients with invasive

Indexed as

cefazolinpopulation pharmacokinetic modelStaphylococcus aureustarget attainmenttherapeutic drug monitoring

Identifiers

PMID39452195
PMCPMC11504871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.